Back to search
FDAFDA · Food and drugs·Recall number D-0328-2021

Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manufactured for: X-GEN Phamaceuticals, Inc. Big Flats, NY 14814. NDC 39822-0310-5

Published April 14, 2021 · Recall initiated: March 19, 2021

Summary

FDA records drug Class II recall D-0328-2021, published April 14, 2021 and initiated March 19, 2021. Recalling firm: X-Gen Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 720 100-count (10x10 blister strips); Lot: Lot # CFMBX, EXP 9/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
X-Gen Pharmaceuticals Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot # CFMBX, EXP 9/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manufactured for: X-GEN Phamaceuticals, Inc. Big Flats, NY 14814. NDC 39822-0310-5 recalled?

Yes. FDA published recall D-0328-2021 on April 14, 2021. Reported hazard: Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay

What should I do if I have this product?

Voluntary: Firm initiated · Letter